1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H1, 2015

Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H1, 2015" provides data on the Corrosive Esophagitis (Erosive Esophagitis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Corrosive Esophagitis (Erosive Esophagitis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Corrosive Esophagitis (Erosive Esophagitis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Corrosive Esophagitis (Erosive Esophagitis) Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Corrosive Esophagitis (Erosive Esophagitis) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Takeda Pharmaceutical Company Limited 30
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 30
AstraZeneca PLC 32
Clinical Trial Overview of AstraZeneca PLC 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Hammersmith Medicines Research Ltd. 34
Clinical Trial Overview of Hammersmith Medicines Research Ltd. 34
CJ HealthCare Corporation 35
Clinical Trial Overview of CJ HealthCare Corporation 35
Kremers Urban Pharmaceuticals Inc. 36
Clinical Trial Overview of Kremers Urban Pharmaceuticals Inc. 36
Khorakiwala Holdings and Investments Private Limited 37
Clinical Trial Overview of Khorakiwala Holdings and Investments Private Limited 37
Ilyang Pharmaceutical Co., Ltd 38
Clinical Trial Overview of Ilyang Pharmaceutical Co., Ltd 38
Eisai Co., Ltd. 39
Clinical Trial Overview of Eisai Co., Ltd. 39
Effexus Pharmaceuticals LLC 40
Clinical Trial Overview of Effexus Pharmaceuticals LLC 40
Clinical Trial Overview of Top Institutes / Government 41
Mayo Clinic 41
Clinical Trial Overview of Mayo Clinic 41
Chang Gung Memorial Foundation 42
Clinical Trial Overview of Chang Gung Memorial Foundation 42
Emory University 43
Clinical Trial Overview of Emory University 43
Landspitali University Hospital 44
Clinical Trial Overview of Landspitali University Hospital 44
Otto-von-Guericke Universitat 45
Clinical Trial Overview of Otto-von-Guericke Universitat 45
The Comprehensive and Integrative Medicine Institute of South Korea 46
Clinical Trial Overview of The Comprehensive and Integrative Medicine Institute of South Korea 46
Five Key Clinical Profiles 47
Appendix 84
Abbreviations 84
Definitions 84
Research Methodology 85
Secondary Research 85
About GlobalData 86
Contact Us 86
Disclaimer 86
Source 86

List of Tables
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 30
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 32
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 33
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hammersmith Medicines Research Ltd., 2015* 34
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by CJ HealthCare Corporation, 2015* 35
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kremers Urban Pharmaceuticals Inc., 2015* 36
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Khorakiwala Holdings and Investments Private Limited, 2015* 37
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ilyang Pharmaceutical Co., Ltd, 2015* 38
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 39
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Effexus Pharmaceuticals LLC, 2015* 40
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 41
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2015* 42
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015* 43
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Landspitali University Hospital, 2015* 44
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otto-von-Guericke Universitat, 2015* 45
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Comprehensive and Integrative Medicine Institute of South Korea, 2015* 46

List of Figures
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Corrosive Esophagitis (Erosive Esophagitis) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Corrosive Esophagitis (Erosive Esophagitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.